The three stocks include:
1. UnitedHealthcare, the country’s biggest health insurer, as the second enrollment period for health insurance exchanges closes Feb. 15. The company offers plans through the exchanges in 23 states.
2. Actavis, a generic drug company that told investors to be excited about releasing fourth quarter and full-year 2014 results later this month. The company expects non-GAAP EPS to outdo Wall Street consensus estimates by around 10 percent.
3. Celgene, a biotech giant focused on cancer treatment. The company currently relies on the multiple myeloma treatment Revlimid, but promising technology including breast cancer treatment and psoriasis drug could make an impact in the future.
More articles on healthcare:
15 statistics on ASC house per case
Where is healthcare the cheapest? 5 cities
5 ways you can reduce outpatient coding denials
